
IPOLYCA
Lycia Therapeutics Prices Its IPO: A Big Bet on Protein Degradation
Lycia Therapeutics Inc. is set to list on Nasdaq on 2026-10-23, and the company has priced its IPO with 17,640,000 shares offered; the price range was not disclosed. The setup is compelling for investors who want exposure to early-stage biotech, but the story still hinges on clinical execution and platform validation.
Oct 21, 20266 MIN